The roles played by ryanodine receptors (RyRs) and inositol 1,4,5-trisphosphate receptors (IP3Rs) in vascular smooth muscle in the microcirculation remain unclear. Therefore, the function of both RyRs and IP3Rs in Ca 2ϩ signals and myogenic tone in hamster cremaster muscle feed arteries and downstream arterioles were assessed using confocal imaging and pressure myography. Feed artery vascular smooth muscle displayed Ca 2ϩ sparks and Ca 2ϩ waves, which were inhibited by the RyR antagonists ryanodine (10 M) or tetracaine (100 M). Despite the inhibition of sparks and waves, ryanodine or tetracaine increased global intracellular Ca 2ϩ and constricted the arteries. (6, 78) . What remains unclear is the role played by these channels in microvascular smooth muscle and the regulation of myogenic tone.
Westcott EB, Jackson WF. Heterogeneous function of ryanodine receptors, but not IP 3 receptors, in hamster cremaster muscle feed arteries and arterioles. Am J Physiol Heart Circ Physiol 300: H1616-H1630, 2011. First published February 25, 2011; doi:10.1152/ajpheart.00728.2010.-The roles played by ryanodine receptors (RyRs) and inositol 1,4,5-trisphosphate receptors (IP3Rs) in vascular smooth muscle in the microcirculation remain unclear. Therefore, the function of both RyRs and IP3Rs in Ca 2ϩ signals and myogenic tone in hamster cremaster muscle feed arteries and downstream arterioles were assessed using confocal imaging and pressure myography. Feed artery vascular smooth muscle displayed Ca 2ϩ sparks and Ca 2ϩ waves, which were inhibited by the RyR antagonists ryanodine (10 M) or tetracaine (100 M). Despite the inhibition of sparks and waves, ryanodine or tetracaine increased global intracellular Ca 2ϩ and constricted the arteries. The blockade of IP3Rs with xestospongin D (5 M) or 2-aminoethoxydiphenyl borate (100 M) or the inhibition of phospholipase C using U-73122 (10 M) also attenuated Ca 2ϩ waves without affecting Ca 2ϩ sparks. Importantly, the IP 3Rs and phospholipase C antagonists decreased global intracellular Ca 2ϩ and dilated the arteries. In contrast, cremaster arterioles displayed only Ca 2ϩ waves: Ca 2ϩ sparks were not observed, and neither ryanodine (10 -50 M) nor tetracaine (100 M) affected either Ca 2ϩ signals or arteriolar tone despite the presence of functional RyRs as assessed by responses to the RyR agonist caffeine (10 mM). As in feed arteries, arteriolar Ca 2ϩ waves were attenuated by xestospongin D (5 M), 2-aminoethoxydiphenyl borate (100 M), and U-73122 (10 M), accompanied by decreased global intracellular Ca 2ϩ and vasodilation. These findings highlight the contrasting roles played by RyRs and IP3Rs in Ca 2ϩ signals and myogenic tone in feed arteries and demonstrate important differences in the function of RyRs between feed arteries and downstream arterioles. microcirculation; ion channels; vascular smooth muscle; inositol 1,4,5-trisphosphate THE SARCOPLASMIC RETICULUM (SR) of vascular smooth muscle cells contains at least two types of Ca 2ϩ -release channels: ryanodine receptors (RyRs) and inositol 1,4,5-trisphosphate (IP 3 ) receptors (IP 3 Rs) (78) . RyRs underlie Ca 2ϩ sparks (15), and they may also participate in more global intracellular Ca 2ϩ events through Ca 2ϩ -induced Ca 2ϩ release (CICR) (78) . Calcium release during G protein-coupled receptor activation is mediated by IP 3 Rs, and these Ca 2ϩ release channels also underlie Ca 2ϩ waves (78) . In some systems, both RyRs and IP 3 Rs contribute to Ca 2ϩ signals (6, 78) . What remains unclear is the role played by these channels in microvascular smooth muscle and the regulation of myogenic tone.
RyR-mediated Ca 2ϩ sparks have been observed in retinal arterioles (21, 22, 76) and ureter arterioles (13). In contrast, recent studies of cells isolated from first-order rat cremaster arterioles failed to detect Ca 2ϩ sparks (82) . However, further studies of ureter arteriolar smooth muscle cells (10) found no role for RyRs in these microvessels. While most studies of smooth muscle from larger vessels suggest that Ca 2ϩ sparks activate sarcolemmal large-conductance Ca 2ϩ -activated K ϩ (BK Ca ) channels and contribute to the negative feedback regulation of membrane potential and vascular tone (78) , studies of renal arterioles suggest that RyRs participate in the positive feedback regulation of vascular tone through CICR in this microcirculation (3, 25, 26) . Thus there appear to be substantial regional differences in the function of RyRs in the microcirculation.
Similarly, the role played by IP 3 Rs in the regulation of myogenic tone in the microcirculation is largely unknown. Recent studies of ureter arterioles suggest that IP 3 Rs play a dominant role in Ca 2ϩ signaling in these vessels during agonist-induced constriction (10). However, the arterioles in these studies were unpressurized, hence the function of IP 3 Rs during pressure-induced myogenic tone was not addressed. In rat first-order cremaster arterioles, the IP 3 R antagonist 2-aminoethoxydiphenyl borate (2-APB) has been reported to inhibit myogenic tone (71) (consistent with a major role for IP 3 Rs) or have little effect (53) . The lack of Ca 2ϩ waves observed in small fluo-4-loaded pressurized mesenteric arteries with substantial myogenic tone (64) would appear to argue against a major role for IP 3 Rs in basal myogenic tone in these vessels. Thus the function of IP 3 Rs in arteriolar and resistance artery smooth muscle and their role in myogenic tone remain unclear.
The purpose of the present study was to characterize the subsarcolemmal Ca 2ϩ signals in smooth muscle cells of small skeletal muscle arterioles compared with those observed in upstream feed arteries and to test the hypothesis that RyRs and IP 3 Rs contribute to Ca 2ϩ signals and myogenic tone in both vessel types. We found that RyRs participate in both Ca 2ϩ sparks and Ca 2ϩ waves in feed artery smooth muscle cells and contribute to the negative feedback regulation of myogenic tone in these small arteries. In contrast, RyRs appeared silent in smooth muscle cells of cremaster arterioles, contributing to neither Ca 2ϩ sparks, Ca 2ϩ waves, nor myogenic tone. On the other hand, we observed that IP 3 Rs and upstream phospholipase C (PLC) importantly contributed to Ca 2ϩ waves, global Ca 2ϩ levels, and myogenic tone in smooth muscle cells of both feed arteries and arterioles. Our findings emphasize the differences in function between RyRs and IP 3 Rs in feed arteries and demonstrate heterogeneity in the function of RyRs in feed arteries compared with their downstream arterioles.
METHODS
Animal and vessel preparation. All experiments were approved by and conducted in accordance with the guidelines of the Institutional Animal Care and Use Committee at Michigan State University and were performed in accordance with the Guide for the Care and Use of Laboratory Animals of the National Research Council (19a). Male golden Syrian hamsters (6 -10 wk, 75-150 g, Harlan) were euthanized by CO2 asphyxiation, followed by cervical dislocation. The right and left cremaster muscles were quickly removed and placed in 4°C Ca 2ϩ -free physiological salt solution (Ca 2ϩ -free PSS) containing (in mM) 137 NaCl, 5.6 KCl, 1 MgCl 2, 10 HEPES, 10 glucose (pH 7.4, 295 mosmol/kgH 2O). Second-order cremaster arterioles were isolated by hand dissection with the aid of a stereomicroscope as previously described (14, 41). Cremaster muscle feed arteries were dissected in situ by surgically exposing the iliac arteries and carefully isolating small artery branches that were upstream from the cremaster muscle microcirculation.
Vessel cannulation. Arterioles and feed arteries with intact endothelium were transferred to a cannulation chamber using a 50 -100-l Wiretrol pipette (Drummond Scientific, Broomal, PA), cannulated onto glass micropipettes, and secured to the pipettes using 11-0 ophthalmic suture (Ashaway Line and Twine, Ashaway, RI). The chamber was then secured to the stage of a microscope (Leica DMIL, Wetzlar, Germany) where the vessels were visualized, heated to 34°C (cremaster arterioles) or 37°C (feed arteries), pressurized to 80 cmH2O and allowed to develop myogenic tone (14, 40). All vessels studied had a minimum of 20% resting myogenic tone compared with the maximum diameters of the vessels obtained in Ca 2ϩ -free PSS. Vessels were constantly superfused with PSS, containing (in mM) 140 NaCl, 5 KCl, 1.8 CaCl2, 1 MgCl2, 10 HEPES, 10 glucose (pH 7.4), alone or containing a drug.
Calcium imaging. The smooth muscle cells of cannulated vessels were loaded with the intensiometric Ca 2ϩ indicator fluo-4 by bath incubation. The dye solution contained 5 M fluo-4 AM dye (Invitrogen, Carlsbad, CA) in 0.5% dimethyl sulfoxide (DMSO) and 0.1% bovine serum albumin (USB, Cleveland, OH) in Ca 2ϩ -free PSS. This solution was applied to the vessels for 2 h at room temperature, followed by a 30-min superfusion with PSS to wash fluo-4 from the bath and to allow for dye deesterification and gradual temperature increase. All vessels were imaged using a long working-distance ϫ40 H 2O immersion objective (numerical aperature, 0.8; and working distance, 3 mm; Leica). Fluo-4 fluorescence at 526 nm was acquired at 30 frames/s using a spinning-disc confocal system (CSU-10B, Solamere, Salt Lake City, UT) with 488 nm laser illumination (Solamere) and an intensified CCD camera (XR Mega-10, Stanford Photonics, Palo Alto, CA). Each recording period was 16.7 s and consisted of 500 1,024 ϫ 1,024 pixel frames captured at 30 frames/s (0.17 ϫ 0.17 m per pixel on our system). The z-resolution with our confocal head (50 m pinholes) and stated objective in PSS was 1.77 m (see http://zeiss-campus.magnet.fsu.edu/articles/ spinningdisk/introduction.html for details). Images were recorded using Piper software (Stanford Photonics) and analyzed using SparkAn (courtesy of Drs. M. T. Nelson and A. D. Bonev, University of Vermont) and ImageJ (1) software. The occurrence of both Ca 2ϩ sparks and Ca 2ϩ waves was counted manually by separately visualizing each smooth muscle cell within a vessel using a masking procedure and scoring whether or not any Ca 2ϩ sparks and/or waves appeared during playback of 500 frame sequences. These occurrences were then verified using SparkAn as increases in fluorescence that were at least 15% above basal levels for each cell for sparks and 20% above baseline for waves.
SparkAn was also used to calculate the average frequency, amplitude (F/F o), and full-duration half maximum (FDHM) of Ca 2ϩ events recorded from cells in vessel walls. In SparkAn, a region of interest (ROI) (10 ϫ 10 pixels) was placed at the peak of Ca 2ϩ events on each cell that displayed at least one Ca 2ϩ event during the recording period. Therefore, the frequency, amplitude, and FDHM represent the average rate of spark or wave occurrence, peak amplitude, or duration of Ca 2ϩ events, respectively, per cell within a vessel. The spatial spread [full-width half maximum (FWHM)] of Ca 2ϩ sparks and waves were determined using ImageJ. Hand-drawn ROIs were first used to calculate the prespark/wave basal Ca 2ϩ level of each smooth muscle cell. FWHM was next calculated by comparing the basal intensity of each cell with plot profiles along lines drawn through the peak fluorescence of each spark or wave.
Calcium transients in smooth muscle cells induced by caffeine (10 mM) were assessed using the ratiometric Ca 2ϩ -indicator fura-2 as previously described (14, 40). Fura-2 was excited at 340 and 380 nm using a DeltaRam X multiwavelength illuminator, and emission at 510 nm was measured using a D-104 photometer (Photon Technologies International, Birmingham, NJ). Both the illuminator and photometer were controlled using FeliX software (Photon Technologies International). Background fluorescence of cannulated arterioles was measured before loading and subtracted from the fluorescence values of the loaded vessels. Smooth muscle cells in cannulated vessels were loaded by bath application of fura-2 (5 M) for 60 min, followed by a 30-min washout period. Diameter was simultaneously measured using Diamtrak software (T. O. Neild, Adelaide, Australia) as described below.
To determine whether Ca 2ϩ waves in hamster cremaster arterioles and hamster feed arteries were synchronous, SparkAn was used to produce a trace of Ca 2ϩ activity in up to 20 cells/vessel by placing 10 ϫ 10 pixel ROIs on each cell that exhibited at least one wave (see Fig. 1C for example). The data from each ROI were then combined by averaging the F/F o of the ROIs across each time point to produce an average trace of global Ca 2ϩ activity in the whole vessel during the recording period (see Fig. 1C ). These averaged tracings were then analyzed to determine the presence of any peaks with fluorescence Ͼ 1.2 Fo.
Measurement of vessel diameters. In fluo-4-loaded feed arteries and arterioles, steady-state diameters were measured asynchronously from Ca 2ϩ measurements. Immediately before Ca 2ϩ measurements, before or after drug administration, the microscope was focused to midplane, the vessels were briefly transilluminated with dim 586-nm light, and a sequence of images were acquired. The microscope was then refocused to the plane of interest for Ca 2ϩ measurements. Internal vessel diameters were then measured using ImageJ from the transilluminated images. The diameter effects of all drugs were verified in preliminary experiments on vessels not loaded with fluo-4 to verify the time course of the drugs to ensure that steady states were achieved and that asynchronous diameter measures accurately represented the steady-state effects of the drugs. Measurements were typically made after 10 -15 min of drug exposure. In all other experiments, vessel internal diameters were continuously measured using Diamtrak software (T. O. Neild) (66), as previously reported (14, 40).
Chemicals. Ryanodine was obtained from Ascent Scientific (Bristol, UK), and xestospongin D and 2-APB, from Calbiochem (San Diego, CA). Fluo-4 was obtained from Invitrogen. All other drugs and chemicals were obtained from Sigma-Aldrich (St. Louis, MO) unless noted otherwise in the text. Caffeine and tetraethyl ammonium (TEA) were dissolved directly into PSS. All other drugs were dissolved in DMSO and then diluted to their final concentrations in PSS. DMSO alone was without effect in cannulated vessels.
Data analysis and statistics. The occurrence of Ca 2ϩ sparks and Ca 2ϩ waves are presented as proportions (number cells with at least 1 occurrence/total number of cells examined) Ϯ 95% confidence intervals, with confidence intervals calculated using QuickCalcs' implementation of the modified Wald method (http://www.graphpad. com/quickcalcs/ConfInterval1.cfm). All other data are expressed as means Ϯ SE. Statistical significance was determined using Student's t-tests, analyses of variance followed by Tukey's test for post hoc comparisons of means, or Kruskall-Wallis test followed by Dunn's multiple comparison test when data were not normally distributed or when group variances were heterogeneous. All statistical comparisons were performed at the 95% confidence level. Table 1 ). Calcium waves also had a significantly longer duration and larger amplitude than Ca 2ϩ sparks, as seen in the representative traces in Fig. 1B and in Table 1 . Calcium waves were asynchronous and were observed throughout the recording period (Fig. 1C) .
RESULTS

Characterization of
The length of smooth muscle cross sections in confocal slices were measured in fluo-4-loaded vessels and compared with the full-width, half maxima (FWHM) of each Ca 2ϩ event. The average smooth muscle cell cross-section length was 85 Ϯ 1.0 m (n ϭ 63 cells from 21 vessels) in feed arteries. Calcium sparks had FWHM that were considerably smaller than crosssection lengths (6.5 Ϯ 0.02%, n ϭ 63 cells from 21 vessels), whereas Ca 2ϩ waves had FWHM that were much closer to the entire cross-section length (68 Ϯ 2%, n ϭ 63 cells from 21 vessels). Calcium sparks significantly differed in frequency, amplitude, and duration (FDHM) compared with waves in feed arteries (Table 1) . Calcium sparks were observed in 32% of feed artery smooth muscle cells (95% confidence interval ϭ 29 -36%; 531 cells from 23 vessels), whereas Ca 2ϩ waves were observed in 55% of cells (95% confidence intervals ϭ 51-59%, 585 cells from 23 vessels, P Ͻ 0.05).
In contrast to our observations in feed arteries and prior studies in other larger vessels, Ca 2ϩ sparks were not observed in the smooth muscle cells of fluo-4-loaded cremaster arterioles: 0 cells displayed Ca 2ϩ sparks out of 586 cells examined in 29 arterioles. Calcium waves, however, were routinely observed in pressurized arterioles: 321 cells displayed Ca 2ϩ waves out of 586 examined in 29 arterioles (55%; 95% confidence interval ϭ 51-59%). The frequency, amplitude, and FDHM of Ca 2ϩ waves were similar to those observed in feed arteries (Table 1) . However, the FWHM of the Ca 2ϩ waves in arteriolar smooth muscle cells was less than that of feed arteries (25 Ϯ 0.5 m, n ϭ 87 cells from 29 vessels). This is consistent with the smaller size of these vessels (average cross-section lengths of confocal slices in the arterioles ϭ 34 Ϯ 0.5 m; P Ͻ 0.05 compared with feed arteries, Table 1 ), as the arteriolar Ca 2ϩ waves occupied 75 Ϯ 1% of slice length, greater than the fraction observed in feed arteries (P Ͻ 0.05). Importantly, Ca 2ϩ waves in arterioles were much larger than Ca 2ϩ sparks observed in the feed arteries (Table 1) . Like the Ca 2ϩ waves observed in feed arteries, arteriolar Ca 2ϩ waves were asynchronous and observed throughout the recording period (Fig. 1C) .
Effects of SR Ca 2ϩ depletion in feed arteries and arterioles. To verify that the Ca 2ϩ signals observed in feed arteries and arterioles originated from intracellular Ca 2ϩ stores, we examined the effects of the smooth sarco(endo)plasmic reticulum Ca 2ϩ -ATPase (SERCA) inhibitor thapsigargin (100 nM) (58) in fluo-4-loaded feed arteries and arterioles (Fig. 2) . This SERCA inhibitor abolished Ca 2ϩ sparks in feed arteries. Before the application of thapsigargin (100 nM), Ca 2ϩ sparks were observed in 43 of 188 smooth muscle cells (22.9%; 95% confidence interval ϭ 17.4 -29.4; n ϭ 3 feed arteries) with mean amplitude of 1.63 Ϯ 0.02 F/F o and frequency of 0.1 Ϯ 0.01 Hz. In the presence of thapsigargin, no Ca 2ϩ sparks were observed in any cells (0 of 201 cells, n ϭ 3 arteries; P Ͻ 0.05).
In both feed arteries and arterioles, the inhibition of SERCA nearly eliminated the occurrence of Ca 2ϩ waves ( (Figs. 3 and 4) . The diameter of both vessel types similarly responded to changes in intravascular pressure in the presence and absence of Ca 2ϩ (Fig. 3 ). In the feed arteries, increases in intravascular pressure had no significant effect on the occurrence, amplitude, or frequency of Ca 2ϩ sparks (Fig. 4) . In contrast, changes in intravascular pressure had comparable effects on Ca 2ϩ waves in feed arteries and arterioles: Ca 2ϩ wave occurrences were increased at 40, 80, and 120 compared with 20 cmH 2 O, Ca 2ϩ wave amplitudes were unaltered by the pressure changes, and Ca 2ϩ wave frequency increased at 80 and 120 compared with 20 and 40 cmH 2 O (Fig. 4) . Calcium sparks were not observed in arterioles at any pressure.
Role of RyRs in feed arteries. Superfusion of feed arteries with the RyR antagonist ryanodine (10 M) abolished the occurrence of Ca 2ϩ sparks: 0 cells out of 118 examined from 6 feed arteries displayed these events (P Ͻ 0.05). Ryanodine (10 M) also significantly reduced the number of smooth muscle cells that displayed Ca 2ϩ waves to 13% (95% confidence interval 7-21%, P Ͻ 0.05, n ϭ 6 vessels) (Fig. 5, A and  B) . The application of ryanodine also led to a significant increase in global fluo-4 intensity, suggesting an increase in intracellular Ca 2ϩ ( Fig. 5C ) and significant vasoconstriction (Fig. 5D ). Because ryanodine may deplete SR Ca 2ϩ stores in some systems (80) , the experiments were repeated using tetracaine (100 M), which blocks RyRs without depleting SR Ca 2ϩ stores (22). Similar results were obtained (Fig. 5 , E-H): both Ca 2ϩ sparks and waves were inhibited, associated with a global increase in Ca 2ϩ and vasoconstriction. The ryanodine-and tetracaineinduced increases in global Ca 2ϩ and the associated vasoconstrictions are consistent with the negative feedback role that has been reported for RyRs in other systems (78) .
To further test the hypothesis that RyRs participate in the negative feedback regulation of feed artery tone, we compared the vasomotor effects of ryanodine with those of the BK Ca channel blockers paxilline (100 nM) (51) or TEA at a concentration of TEA (1 mM) that we have previously shown to selectively inhibit BK Ca channels in hamster vascular smooth muscle (11, 12). We verified that paxilline (100 nM) and TEA (1 mM) were equieffective on feed artery diameter. From a resting diameter of 155.4 Ϯ 3.8 m, paxilline (100 nM) constricted feed arteries by 37.7 Ϯ 3.9 m. In the same vessels, TEA (1 mM) produced similar constriction of 43.8 Ϯ 6.3 m (n ϭ 4, P Ͼ 0.05). Thus the concentrations of the BK Ca channel blockers used appeared to have equivalent effects in these vessels.
Alone, both paxilline ( Fig. 6A ) and ryanodine ( Fig. 6 , B, D, and E) caused significant constriction of feed arteries. However, in the presence of paxilline (100 nM), ryanodine (10 M) caused no additional constriction (Fig. 6A) , consistent with published studies implicating the functional coupling of RyRs and BK Ca channels (78) . If the order of application of the drugs were reversed, ryanodine (10 M) only attenuated the paxilline-induced constriction of feed arteries (Fig. 6B) . Identical results were obtained with TEA (1 mM) (Fig. 6, C and D) . These data suggest that while the activity of RyRs may be functionally linked to BK Ca channels, they are not the only regulators of BK Ca channel activity.
To verify that it was not simply the constriction induced by paxilline (100 nM) or TEA (1 mM) that inhibited responses to ryanodine (10 M) (Fig. 6, A and C) , the effects of this RyR antagonist were examined in the absence (Fig. 6E ) and presence of a similar level of constriction induced by the L-type Ca 2ϩ channel agonist Bay K 8644 (5 nM) (Fig. 6F ). As can be seen in Fig. 6F , ryanodine (10 M) still was able to induce vasoconstriction in the Bay K 8644 preconstricted arteries. These data suggest that the loss of response to ryanodine that was observed in the presence of paxilline (100 nM) or TEA (1 mM) (Fig. 6 , A and C) was not simply due to the constriction induced by these BK Ca channel blockers.
The effects of TEA were also examined in fluo-4-loaded feed arteries (Fig. 7, A-C) . In contrast to the effects of ryanodine (10 M), the BK Ca channel blocker increased the occurrence, amplitude, and frequency of Ca 2ϩ waves, while increasing global Ca 2ϩ and constricting the arteries (Fig. 7, A-C) . The increase in occurrence and frequency of Ca 2ϩ waves prevented an accurate quantitation of feed artery Ca 2ϩ spark activity in the presence of TEA.
Lack of a role for RyRs in arterioles. Consistent with the absence of Ca 2ϩ sparks in smooth muscle cells of cremaster arterioles, we found that ryanodine (10 M) had no significant effect on Ca 2ϩ signals in these microvessels: in the presence of ryanodine, Ca 2ϩ waves were still observed (n ϭ 10, P Ͼ 0.05). To rule out the possibility that the concentration of ryanodine used was insufficient, we repeated these experiments using a higher concentration of this alkaloid (50 M) and obtained similar results: ryanodine (50 M) had no effect on Ca 2ϩ wave occurrence, amplitude, or frequency (Fig. 8, A-C) . Consistent with the lack of effect of ryanodine on Ca 2ϩ waves, this alkaloid also was without significant effect on global intracellular Ca 2ϩ (Fig. 8B ) and arteriolar diameter (Fig. 8C ). Tetracaine (100 M, Fig. 8, D-F) , another RyR antagonist, was also without significant effect on any of the parameters measured.
Functional evidence for expression of RyRs in arterioles and efficacy of ryanodine. Because ryanodine had no effect in the arterioles, we examined the functional expression of RyRs using the RyR agonist caffeine (78) (10 mM, Fig. 9 ) and the ability of ryanodine to block the effects of caffeine as a test of the efficacy of ryanodine (Fig. 9, C and D) . Similar to Hill et al. (34), we found that caffeine had biphasic effects on both intracellular Ca 2ϩ and vessel diameter in arterioles pressurized to 80 cmH 2 O that were difficult to interpret (Fig. 9A) . However, vessels pressurized to 20 cmH 2 O, with little myogenic tone, consistently responded to caffeine (10 mM) with a typical, transient increase in intracellular Ca 2ϩ that was associated with a transient constriction (Fig. 9B , n ϭ 7, P Ͻ 0.05).
In separate experiments, we found that ryanodine (10 or 50 M) abolished the caffeine-induced constriction (Fig. 9, C and  D) , confirming that ryanodine effectively blocks RyRs in the arterioles. As above, ryanodine alone did not affect resting arteriolar diameter (Fig. 9, C and D) .
Consistent with the lack of effect of ryanodine on Ca 2ϩ signals or diameter, ryanodine also had no effect on responses induced by the BK Ca channel blockers paxilline (100 nM, Fig. 10, A and B) or TEA (1 mM) (Fig. 10, B and C) , suggesting that RyRs and BK Ca channels are not functionally coupled in arterioles. Thus, in contrast to our findings in feed arteries, RyRs appeared to be silent in arteriolar smooth muscle cells, contributing to neither Ca 2ϩ signals nor myogenic tone in arterioles under the conditions of our experiments.
Similar to the effects of TEA on Ca 2ϩ waves in feed arteries, this BK Ca channel blocker significantly increased the occurrence of Ca 2ϩ waves in arterioles (Fig. 7D ). There was a tendency for increased amplitude and frequency of Ca 2ϩ waves in the presence of TEA, but these did not attain statistical significance. However, the global fluo-4 intensity was significantly increased (Fig. 7E) , accompanied by a significant decrease in diameter (Fig. 7F) (Fig. 11B) . Similar results were obtained using 2-APB (100 M) (Fig. 11F) , another putative IP 3 R antagonist. Consistent with a role for IP 3 and IP 3 Rs in the mechanisms underlying Ca 2ϩ waves, we also found that an inhibitor of PLC, U-73122 (10 M), greatly attenuated the occurrence, amplitude, and frequency of Ca 2ϩ waves in feed artery smooth muscle cells (Fig. 11J) . The inactive analog of this compound (U-73343, 10 M) was without effect: Ca 2ϩ spark and Ca 2ϩ wave occurrence, amplitude, and frequency were not significantly different from values in PSS, and global Ca 2ϩ and vessel diameter were also unaffected by U-73343 (P Ͼ 0.05, n ϭ 6). However, in distinct contrast to the effects of ryanodine on Ca 2ϩ sparks, neither the IP 3 R antagonists (xestospongin D or 2-APB) nor the PLC inhibitor (U-73122) had any effect on the occurrence, amplitude, or frequency of Ca 2ϩ sparks in feed artery smooth muscle cells (Fig. 11, A, E, and I) . Similarly, the spatial spread (FWHM) and duration (FDHM) of Ca 2ϩ sparks were not significantly affected by xestospongin D, 2-APB, or U-73122 (Table 2 ).
In contrast to the effects of ryanodine or tetracaine on global Ca 2ϩ and diameter in feed arteries, xestospongin D, 2-APB, or U-73122 each reduced global Ca 2ϩ signals and dilated the feed arteries (Fig. 11, C and D, G and H, and K and L) . The dramatic effects of the IP 3 R antagonists in feed arteries indicate that unlike RyRs, IP 3 Rs are not involved in the negative feedback regulation of myogenic tone in these small arteries.
Role of IP 3 Rs in arteriolar smooth muscle. Similar to our observations in feed arteries, we found that antagonists of IP 3 Rs (xestospongin D or 2-APB) and an inhibitor of PLC (U-73122) nearly abolished the occurrence of Ca 2ϩ waves in cremaster arterioles and significantly decreased the amplitude of the remaining waves (Fig. 12, A, D, and G) . Both 2-APB and U-73122 also significantly reduced the frequency of the residual waves (Fig. 12, D and G) . Xestospongin D tended to reduce the Ca 2ϩ wave frequency, but this did not attain statistical significance (P ϭ 0.07; Fig. 12A ). As was observed in feed arteries, these antagonists also reduced global Ca 2ϩ levels and dilated the arterioles (Fig. 12, B and C, E and F, and H and I 2ϩ spark properties in intact, pressurized vessels, and three of these studies used vessels that had significant myogenic tone (33, 61, 64). Three of the above studies also measured only the frequency of Ca 2ϩ sparks, making comparisons between the studies difficult. Thus there appears to be considerable variability in Ca 2ϩ spark morphology and kinetics. In hamster cremaster feed arteries, we observed localized Ca 2ϩ signals that were inhibited by the RyR antagonists ryanodine (10 m) and tetracaine (100 m) and the SERCA inhibitor thapsigargin (100 nM) but unaffected by the IP 3 R antagonists xestospongin D (5 M) or 2-APB (100 M) or the PLC antagonist U-73122 (10 M). Based on their small spatial spread (Table 1 ) and this pharmacology, we have classified these signals as Ca 2ϩ sparks. The amplitude of these Ca 2ϩ sparks appear within the range of values reported in other systems (see preceding paragraph). However, the spatial spread (FWHM) and the duration (FDHM) that we report appear larger than what has been observed in other systems (see preceding paragraph). We do not have an explanation for this discrepancy. All of the studies outlined above used vessels or isolated cells from different vascular beds and different species of animals, and experimental conditions (temperature, pressure, solutions, etc.) varied significantly between the studies. Therefore, it is difficult to determine whether the differences in spark characteristics that we report are species related, vascular bed related, or simply due to differences in the tools used to study these cells. It is likely that a combination of all these factors contributed to the apparent heterogeneity, and more work needs to be done, especially in intact vessels, to clearly define the properties of Ca 2ϩ sparks in native vascular smooth muscle cells.
Under control conditions, both feed arteries and arterioles produced asynchronous Ca 2ϩ waves, whereas only feed arteries produced Ca 2ϩ sparks. These differences are not the result of nonequivalent intravascular pressures, as four different pressure steps caused similar changes in myogenic tone and Ca 2ϩ signals in both vessel types. Our data are consistent with recent studies in cerebral arteries by Mufti et al. (65) , suggesting that increases in intravascular pressure have a greater effect on the occurrence and frequency of asynchronous Ca 2ϩ waves at pressures steps below 80 cmH 2 O. However, our studies differ from those by Jaggar (42) who found that increases in intravascular pressure led to an increase in Ca 2ϩ spark frequency in cerebral artery smooth muscle, whereas pressure had no effect on the occurrence, amplitude, or frequency of Ca 2ϩ sparks in our studies over a similar range of pressures.
In feed arteries, we found that the RyR antagonists ryanodine (10 M) and tetracaine (100 M) and the SERCA antagonist thapsigargin (100 nM) inhibited both Ca 2ϩ sparks and Ca 2ϩ waves, led to an elevation in global Ca 2ϩ , and produced vasoconstriction. These data are consistent with a number of prior studies and further support the hypothesis that RyRs, likely through their functional coupling to BK Ca channels, participate in the negative feedback regulation of myogenic tone in resistance arteries (27, 52, 68) . Consistent with this hypothesis, we found that ryanodine-induced constriction of feed arteries was eliminated in the presence of the BK Ca channel blockers paxilline (100 nM) or TEA (1 mM). Thus we think that in feed arteries, the loss of RyR function due to block of RyRs (ryanodine or tetracaine) or depletion of Ca 2ϩ stores (thapsigargin) leads to decreased BK Ca channel activity, membrane depolarization, and increased Ca 2ϩ influx through voltage-gated Ca 2ϩ channels as has been previously postulated (68) . A portion of the Ca 2ϩ increase and vasoconstriction induced by thapsigargin (100 nM) likely results from Ca 2ϩ store depletion-induced cation entry contributing to the depolarization and Ca 2ϩ increase as previously shown in first-order rat cremaster arterioles (71) .
In contrast to the effects of the BK Ca channel blockade on responses to ryanodine, ryanodine only blunted paxilline-or TEA-induced vasoconstriction in feed arteries. These data suggest that Ca 2ϩ release through RyRs only provides a fraction of the signal responsible for activity of BK Ca channels and that Ca 2ϩ from other sources likely contributes to the regulation of BK Ca channels in hamster feed arteries.
Our observation that ryanodine or tetracaine also inhibit Ca 2ϩ waves in feed arteries supports prior studies in several smooth muscles (19, 29, 32, 37), including retinal arteriolar smooth muscle cells (76) , where RyRs contribute to Ca 2ϩ waves, likely through CICR. Our studies differ from reports in renal afferent arterioles where ryanodine dilates the arterioles and reduces agonist-induced vasoconstriction (3). These data support our contention that there is significant regional heterogeneity in the function of RyRs in vascular smooth muscle cells. It is also possible that the inhibitory effect of ryanodine (10 M) on Ca 2ϩ waves in feed arteries was due to ryanodineinduced depletion of intracellular stores (36, 38) or other effects of ryanodine or tetracaine on IP 3 R-mediated Ca 2ϩ signals (59) . However, we found that Ca 2ϩ waves in secondorder cremaster arterioles were unaffected by ryanodine (10-50 M) or tetracaine (100 M), suggesting that such off-target effects are unlikely. Further studies will be required to determine the precise role played by RyRs in Ca 2ϩ wave genesis in feed arteries. In contrast to our findings in the feed arteries, we were unable to detect Ca 2ϩ sparks in cremaster arterioles using identical methods. Supporting these observations, we found that the RyR antagonists ryanodine (10 -50 M) or tetracaine (100 M) had no effect on Ca 2ϩ wave dynamics, global intracellular Ca 2ϩ , myogenic tone, or constriction induced by the BK Ca channel blockers paxilline (100 nM) or TEA (1 mM) in pressurized second-order cremaster arterioles. These data suggest that RyRs do not participate in Ca 2ϩ signaling underlying myogenic tone in second-order skeletal muscle arterioles, at least under the conditions of our experiments. We cannot exclude the possibility that we may have missed some population of short-duration, low-amplitude events mediated by RyRs in the arterioles. However, if such events were present, then they were not coupled to other Ca 2ϩ signals or to the regulation of myogenic tone in these microvessels, because neither ryanodine (10 -50 M) nor tetracaine (100 M) produced any significant effects in the arterioles. The lack of effect of ryanodine (10 -50 M) and tetracaine (100 M) in the arterioles, despite the presence of apparently functional RyRs, as assessed by caffeine-induced Ca 2ϩ transients and constriction, also suggests that the effects of ryanodine and tetracaine observed in feed arteries are not simply off-target as noted above.
Our findings of no Ca 2ϩ sparks in smooth muscle cells of second-order cremasteric arterioles are in agreement with recent studies on smooth muscle cells isolated from first-order rat cremasteric arterioles by Yang et al. (82) , who also failed to detect Ca 2ϩ sparks in their experiments, and recent observations in precapillary arterioles in ureter and vas deferens (10). However, in contrast to the study by Yang et al. (82) , who found that ryanodine significantly constricted first-order rat cremaster arterioles studied via pressure myography, we found that neither ryanodine (10 -50 M) nor tetracaine (100 M) had any significant effect on diameter or intracellular Ca 2ϩ signals in second-order hamster cremaster arterioles. This difference between arteriolar branch order may mean that firstorder arterioles are transitional between feed arteries, where we found that ryanodine or tetracaine inhibited Ca 2ϩ sparks and waves and produced robust vasoconstriction, and second-order arterioles, where RyRs appeared to be silent. We do not think that our data can be explained by a complete lack of RyRs or a lack of efficacy of ryanodine in the arterioles. Caffeine produced robust Ca 2ϩ transients in arteriolar smooth muscle cells, demonstrating the functional presence of RyRs. Furthermore, we were able to block the effects of caffeine with ryanodine (10 -50 M), verifying that the concentrations of this alkaloid that we used effectively inhibited RyRs. Thus our data suggest that RyRs play little role in the regulation of basal myogenic tone in second-order hamster arterioles in contrast to the negative feedback role reported in arterial smooth muscle (44, 52, 68, 83) . Our findings are also in contrast to observations made in rat retinal arterioles, where RyR-based Ca 2ϩ sparks have been previously reported (21, 22) and appear to contribute to global Ca 2ϩ signaling (76) . RyRs also appear to contribute to positive-feedback CICR in rat renal preglomerular arterioles (25, 26). Taken with our results, these data from retinal and renal arterioles support the hypothesis that there are substantial regional differences in the function of RyRs in arteriolar smooth muscle cells, as well as differences in RyR function between arterioles and upstream feed arteries.
The lack of effect of ryanodine (10 -50 M) and tetracaine (100 M) on Ca 2ϩ signals, myogenic tone, and paxilline-or TEA-induced constriction in second-order arterioles also suggests that the source of Ca 2ϩ responsible for the regulation of BK Ca channels in these microvessels is likely different from what has been reported in arterial smooth muscle, where Ca 2ϩ sparks importantly control BK Ca channel function and smooth muscle excitability (27, 44, 52, 68) . Studies in neurons (5, 30, 75) and coronary smooth muscle (31) have suggested that Ca 2ϩ influx through voltage-gated Ca 2ϩ channels may also regulate BK Ca channels. Our preliminary studies in cremaster arterioles are consistent with this hypothesis (7) . Further studies will be required to critically test this hypothesis in the microcirculation.
Our studies do not illuminate the mechanisms responsible for the differences in function of RyRs between vessels. However, prior studies in other smooth muscles have suggested that the pattern of RyR isoform expression can significantly alter the function of RyRs (20, 49, 50, 57, 87) . RyR isoforms 1 and/or 2 appear essential for Ca 2ϩ spark formation (20, 49), whereas RYR3 (57) or a spliced variant of this isoform (50) may be inhibitory to Ca 2ϩ sparks. Preliminary studies in mouse cremaster feed arteries and their downstream arterioles are consistent with our functional studies performed in hamster vessels and indicate differences in expression of RyR isoforms that could underlie the functional differences between arteries and arterioles (55) . Additional research will be required to determine whether differences in RyR isoform expression underlie the differences observed between feed arteries and arterioles.
We found that smooth muscle cells in pressurized small arteries and their downstream arterioles, which develop similar levels of myogenic tone, consistently displayed Ca 2ϩ waves in the absence of added agonist. Our observations are different from those obtained in rat small mesenteric arteries (64) , where only 7% of cells generated Ca 2ϩ waves due to pressureinduced myogenic tone, and recent studies from rat mesenteric and vas deferens arterioles and arteries, where Ca 2ϩ oscillations were not observed in unpressurized vessels in the absence of vasoconstrictor agonists (10). These data support the notion that there are significant regional differences in mechanisms regulating and underlying Ca 2ϩ signaling and myogenic tone. We found that a PLC inhibitor (U-73122, 10 M) and two structurally different IP 3 , and inhibited myogenic tone in feed arteries and cremaster arterioles. These data support a large body of evidence implicating PLC in the genesis of myogenic tone (2, 17, 39, 46, 47, 69) and extend a recent report in vas deferens arterioles, suggesting a central role for IP 3 Rs in the regulation of agonist-induced arteriolar tone (10). Recent studies suggest that U-73122 may act to deplete intracellular Ca 2ϩ stores (60). We do not think that the depletion of Ca 2ϩ stores can explain the inhibitory effect of U-73122 on Ca 2ϩ waves that we observed, because this PLC inhibitor had no effect on RyR-based Ca 2ϩ sparks in feed arteries. In smooth muscle, RyRs and IP 3 Rs appear to access the same pool of Ca 2ϩ (62) . Thus the lack of effect of U-73122 on Ca 2ϩ sparks argues against this agent working by depletion of intracellular Ca 2ϩ stores in our studies. Furthermore, we found that the SERCA inhibitor thapsigargin (100 nM), while abolishing Ca 2ϩ sparks and Ca 2ϩ waves, also produced a significant increase in global Ca 2ϩ and vasoconstriction in both feed arteries and arterioles, opposite the effects of U-73122 and the IP 3 R antagonists. Along with the lack of effect of U-73122 on Ca 2ϩ sparks, this argues against store depletion as the primary means by which U-73122 produced effects in feed arteries and arterioles. Both 2-APB (9) and xestospongins (70) are known to have effects on other ion channels in addition to IP 3 Rs. As Ca 2ϩ sparks in feed arteries were unaffected by these agents, we can rule out the depletion of intracellular stores or effects on RyRs as common off-target mechanisms. Thus we speculate that the fall in intracellular Ca 2ϩ and consequent vasodilation observed with U-73122, xestospongin D, and 2-APB result from the inhibition of IP 3 R-based Ca 2ϩ waves and the loss of Ca 2ϩ signal amplification as a consequence of inhibited IP 3 formation (U-73122) or blockade of IP 3 Rs (xestospongin D or 2-APB) and not because of possible off-target effects of the inhibitors. The inhibition of SERCA with thapsigargin (100 nM) also abolishes Ca 2ϩ waves but results from the depletion of Ca 2ϩ stores, the stimulation of Ca 2ϩ entry through store-dependent mechanisms, and the likely depolarization-induced activation of Ca 2ϩ influx through voltagegated Ca 2ϩ channels as has been previously observed (59 waves in hamster feed arteries), the major function of RyRs in the feed arteries appears to be in the negative feedback regulation of myogenic tone, as discussed above. Thus RyRs and IP 3 Rs serve distinct, contrasting roles in the regulation of myogenic tone in feed arteries, whereas only the positive feedback function of IP 3 Rs appeared functional in cremaster arterioles. We cannot exclude a possible modulatory role of the endothelium in our study, because all of the vessels used were endothelium intact. We do not think that any of the responses observed were strictly endothelium dependent for the following reasons. We have previously shown that endothelial cells from hamster second-order cremaster arterioles do not appear to express functional RyR, as caffeine (10 mM) does not elicit Ca 2ϩ transients in these cells (18). Thus, at least in the arterioles, we do not think that the lack of effect of ryanodine and tetracaine can be explained by some effect on endothelial cells. The inhibitors of the IP 3 pathway (xestospongin D, 2-APB, and U-73122) all should inhibit endothelial cell Ca 2ϩ signaling (18) and, if anything, tend to produce vasoconstriction. This is the opposite of what was observed in the feed arteries and arterioles. Conversely, thapsigargin should increase endothelial cell Ca 2ϩ and produce vasodilation (63), again opposite of what was observed in both classes of vessel. However, we cannot exclude the possibility that the endothelium may have blunted some of the effects observed. This is a limitation of our experimental design.
Overall, our studies demonstrate that there are important differences in the regulation of both smooth muscle cell Ca 2ϩ signals and myogenic tone between feed arteries and their downstream arterioles. The well-documented negative-feedback role played by RyRs in the regulation of myogenic tone does not appear to hold true in second order hamster cremaster arterioles. In contrast, PLC and IP 3 Rs appear to function similarly in cremaster feed artery and arteriolar smooth muscle cells. The differences we observed between feed arteries and downstream arterioles caution the extrapolation of data gathered in arteries to arterioles and vice versa, even in closely related vasculatures. These differences in mechanisms also point to potential, novel therapeutic targets to modulate the tone of arterioles, for example, independent from upstream resistance arteries. Such microvessel-specific therapeutic targeting would allow the modulation of tissue blood flow and within-organ blood flow distribution potentially without substantial effects on systemic blood pressure and side effects, like orthostatic hypotension, which often result from drugs that nonspecifically target both resistance arteries and arterioles. 
